<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>US Stock Ranking on FinanClub</title>
    <link>https://finan.club/tags/us-stock-ranking/</link>
    <description>Recent content in US Stock Ranking on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 23 Mar 2024 09:05:17 +0000</lastBuildDate><atom:link href="https://finan.club/tags/us-stock-ranking/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>US Stocks Picked</title>
      <link>https://finan.club/us/ranking/</link>
      <pubDate>Sat, 23 Mar 2024 09:05:17 +0000</pubDate>
      
      <guid>https://finan.club/us/ranking/</guid>
      <description>IBRX (ImmunityBio, Inc.) Small ImmunityBio shows promise in advancing immunotherapy treatments for HIV and cancer, with potential financial support for commercialization efforts.
SLB (Schlumberger Limited) Middle Considering the positive sentiment from Wall Street analysts, potential for further stock price gains, and strategic investments in energy projects, Schlumberger (SLB) may be a favorable investment option in the energy technology sector despite market volatility.</description>
    </item>
    
  </channel>
</rss>
